Advantages of a Two-Stage Randomized Trial Design to Evaluate Antimicrobial Treatment Strategies: a Simulation Study

Clicks: 23
ID: 328483
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #120 of 378 articles by views in american journal of epidemiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 378 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
ABSTRACT Background Antimicrobial prescribing policies affect not only treated patients but also their contacts. Two-stage randomized (2SR) designs can be used to estimate these spillover effects, yet this study design has not been widely applied to evaluate antimicrobial strategies. Methods We developed a stochastic agent-based model that simulates a hospital ward with two competing bacterial strains (drug-A-susceptible and drug-A-resistant). We used the simulation to emulate a 2SR trial: six hospital ward clusters were randomized 1:1 to either a 90/10 (90% Drug A, 10% Drug B, drug B was assumed to have no known resistance) or 50/50 treatment allocation strategy; individuals within clusters were then randomized to Drug A or Drug B following the assigned cluster-level allocation strategy. We estimated direct, indirect, total, and overall causal effects on incident infection and mortality. Sensitivity analyses varied the treatment effect, transmission rate, mortality structure, and number of clusters. Results The direct effect of drug choice showed that Drug A recipients had higher mortality (due to non-concordant treatment of resistant infections). This effect varied over time as the ward’s strain ecology diverged between strategies. There was also an indirect effect for Drug A recipients—reflecting spillover from higher resistant-strain prevalence under 90/10—but it was approximately null for Drug B recipients, whose broad-spectrum coverage insulated them from changes in the ward strain distribution. The overall effect—the policy-level comparison—showed that the 50/50 strategy reduced total mortality, but this net benefit concealed a redistribution: resistant-strain deaths decreased while susceptible-strain deaths increased, a consequence captured by the overall effect but invisible to the direct effect. These findings were qualitatively consistent across all sensitivity scenarios. Conclusions We demonstrate that antimicrobial prescribing produces spillover effects not captured by conventional individually randomized trials. These effects can substantially alter treatment outcomes in a population. We propose that the 2SR design, grounded in a formal causal framework for interference, is better suited for evaluating population-level effects of antimicrobial strategies—whether implemented as a randomized trial or emulated with observational data.
Reference Key
openalex_W7138963033 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Juan Gago, Christopher Boyer, Marc Lipsitch
Are you one of these authors? Claim your profile
Journal american journal of epidemiology
Year 2026
DOI
10.1093/aje/kwag220
URL
https://doi.org/10.1093/aje/kwag220
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.